Sex differences in mortality following acute coronary syndromes

JAMA

Volumn 302, Issue 8, 2009, Pages 874-882

  Berger, Jeffrey S ^a,b   Elliott, Laine ^c   Gallup, Dianne ^c   Roe, Matthew ^b   Granger, Christopher B ^b   Armstrong, Paul W ^d   Simes, R John ^e   White, Harvey D ^f   Van De Werf, Frans ^g   Topol, Eric J ^h   Hochman, Judith S ^a   Newby, L Kristin ^b   Harrington, Robert A ^b   Califf, Robert M ^c   Becker, Richard C ^b   Douglas, Pamela S ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF SYDNEY   (Australia)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; HIRUDIN; HIRULOG; LAMIFIBAN; PLACEBO; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; HOSPITALIZATION; META ANALYSIS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 69249221632     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1227     Document Type: Article

References (54)

1. Rosamond W, Flegal K, Friday G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics- 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-e171.
2. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A community-wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation. 1993; 87(6):1947-1953. (Pubitemid 23165638)
3. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women? Circulation. 1995;91(6):1861-1871.
4. Chang WC, Kaul P, Westerhout CM, et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med. 2003; 163(20):2476-2484. (Pubitemid 37385790)
5. Chua TP, Saia F, Bhardwaj V, et al. Are there gender differences in patients presenting with unstable angina? Int J Cardiol. 2000;72(3):281-286. (Pubitemid 30079691)
6. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343(1):8-15. (Pubitemid 30447986)
7. Gottlieb S, Harpaz D, Shotan A, et al; Israeli Thrombolytic Survey Group. Sex differences in management and outcome after acute myocardial infarction in the 1990s: a prospective observational community-based study. Circulation. 2000;102(20):2484-2490. (Pubitemid 30839538)
8. Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators: Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1997;30(1):141-148.
9. Kostis JB, Wilson AC, O'Dowd K, et al. Sex differences in the management and long-term outcome of acute myocardial infarction: a statewide study: MIDAS study group: Myocardial Infarction Data Acquisition System. Circulation. 1994;90(4):1715-1730.
10. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction: results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med. 1992;152(5):972-976.
11. Nicolau JC, Auxiliadora Ferraz M, Nogueira PR, Coimbra Garzon SA, Serrano CV Jr, Ramires JA. The role of gender in the long-term prognosis of patients with myocardial infarction submitted to fibrinolytic treatment. Ann Epidemiol. 2004;14 (1):17-23. (Pubitemid 37510045)
12. Roger VL, Farkouh ME, Weston SA, et al. Sex differences in evaluation and outcome of unstable angina. JAMA. 2000;283(5):646-652. (Pubitemid 30069181)
13. Vaccarino V, Berkman LF, Krumholz HM. Longterm outcome of myocardial infarction in women and men: a population perspective. Am J Epidemiol. 2000; 152(10):965-973. (Pubitemid 30840146)
14. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction: National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341(4):217-225.
15. Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy: GUSTO-I investigators. JAMA. 1996;275(10):777-782. (Pubitemid 26087199)
16. Woodfield SL, Lundergan CF, Reiner JS, et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol. 1997; 29(1):35-42. (Pubitemid 27028717)
17. Reynolds HR, Farkouh ME, Lincoff AM, et al; GUSTO V Investigators. Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V. Arch Intern Med. 2007; 167(19):2054-2060.
18. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham study. JAMA. 1988;260(23):3456-3460.
19. Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community- wide perspective. J Clin Epidemiol. 1993; 46(3):245-252. (Pubitemid 23107072)
20. Vaccarino V, Krumholz HM, Mendes de Leon CF, et al. Sex differences in survival after myocardial infarction in older adults: a community-based approach. J Am Geriatr Soc. 1996;44(10):1174-1182. (Pubitemid 26338830)
21. Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med. 1992;116(10):785-790.
22. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes: Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med. 1999; 341(4):226-232.
23. Nicholls SJ, Tuzcu EM, Crowe T, et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol. 2006;47(10):1967-1975.
24. Oe K, Shimizu M, Ino H, et al. Effects of gender on the number of diseased vessels and clinical outcome in Japanese patients with acute coronary syndrome. Circ J. 2002;66(5):435-440. (Pubitemid 34498713)
25. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329(10):673-682.
26. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 1996;335(11):775-782.
27. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337(16):1118-1123.
28. Van De Werf F, Adgey J, Ardissino D, et al; Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double- blind randomised trial. Lancet. 1999;354(9180): 716-722.
29. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358(9282):605-613.
30. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003; 108(2):135-142. (Pubitemid 36871293)
31. White H; Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombinspecific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet. 2001;358(9296):1855-1863.
32. Kleiman NS, Lincoff AM, Flaker GC, et al; PURSUIT Investigators. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. Circulation. 2000;101(7):751-757.
33. The PARAGON Investigators: Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation. 1998;97(24): 2386-2395.
34. Moliterno DJ; The PARAGON B International Steering Committee. Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGONB study. Am Heart J. 2000;139(4):563-566.
35. Simoons ML; GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS Randomised Trial. Lancet. 2001;357(9272): 1915-1924. (Pubitemid 32568331)
36. Lee KL, Woodlief LH, Topol EJ, et al; GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation. 1995;91(6):1659-1668.
37. Boersma E, Pieper KS, Steyerberg EW, et al; The PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. Circulation. 2000; 101(22):2557-2567. (Pubitemid 30350632)
38. Rosengren A, Wallentin L, K Gitt A, Behar S, Battler A, Hasdai D. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J. 2004;25(8):663- 670.
39. Blomkalns AL, Chen AY, Hochman JS, et al; CRUSADE Investigators. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45(6):832-837.
40. Dotevall A, Hasdai D, Wallentin L, Battler A, Rosengren A. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes: data from the Euro Heart Survey ACS. Diabet Med. 2005;22(11):1542-1550. (Pubitemid 41641162)
41. Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J. 1993;126(4):937-945. (Pubitemid 23291377)
42. Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C. Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J. 1984;5(5):374-381. (Pubitemid 14102185)
43. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-1136.
44. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation. 1990;82(6):2044-2051.
45. Yellon DM, Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res. 2000;87(7):543-550. (Pubitemid 30745348)
46. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA. 1989; 261(14):2077-2086. (Pubitemid 19097969)
47. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359(9302):189-198. (Pubitemid 34113814)
48. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92(7): 1701-1709.
49. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol. 1995;76(9):24C-33C.
50. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82 (3):269-272. (Pubitemid 29429595)
51. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97(21):2110-2116. (Pubitemid 28262117)
52. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93(7):1354-1363. (Pubitemid 26099346)
53. Hlatky MA, Califf RM, Harrell FE Jr, Lee KL, Mark DB, Pryor DB. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11(2):237-245.
54. Näslund U, Grip L, Fischer-Hansen J, Gundersen T, Lehto S, Wallentin L. The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points. Eur Heart J. 1999;20(10):771-777. (Pubitemid 29209911)